The role of traditional Chinese herbal medicines in cancer therapy--from TCM theory to mechanistic insights

Author(s): Hsiao WL, Liu L

Abstract

Traditional Chinese medicine-based herbal medicines have gained increasing acceptance worldwide in recent years and are being pursued by pharmaceutical companies as rich resources for drug discovery. For many years, traditional Chinese medicines (TCM) have been applied for the treatment of cancers in China and beyond. Herbal medicines are generally low in cost, plentiful, and show very little toxicity or side effects in clinical practice. However, despite the vast interest and ever-increasing demand, the absence of strong evidence-based research and the lack of standardization of the herbal products are the main obstacles toward the globalization of TCM. In recent years, TCM research has greatly accelerated with the advancement of analytical technologies and methodologies. This review of TCM specifically used in the treatment of cancer is divided into two parts. Part one provides an overview of the philosophy, approaches and progress in TCM-based cancer therapy. Part two summarizes the current understanding of how TCM-derived compounds function as anticancer drugs.

Similar Articles

Interactions between traditional Chinese medicines and Western therapeutics

Author(s): Chan E, Tan M, Xin J, Sudarsanam S, Johnson DE

The Role of Coenzyme Q10 in Heart Failure

Author(s): Weant KA, Smith KM

The impact of coenzyme Q10 on systolic function in patients with chronic heart failure

Author(s): Sander S, Coleman CI, Patel AA, Kluger J, White CM

Studies on the constituents of Japanese and Chinese crude drugs

Author(s): Shibata S, Fujita M, Itokawa H, Tanaka O, Ishii T

Estrogen-like activity of ginsenoside Rg1 derived from Panax notoginseng

Author(s): Chan RY, Chen WF, Dong A, Guo D, Wong MS

[Chemical studies of crude drugs (1)

Author(s): Kitagawa I, Yoshikawa M, Yoshihara M, Hayashi T, Taniyama T

Apoptotic effects of ginsenoside Rh2 on human malignant melanoma A375-S2 cells

Author(s): Fei XF, Wang BX, Tashiro S, Li TJ, Ma JS, et al.

Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells

Author(s): Kim HS, Lee EH, Ko SR, Choi KJ, Park JH, et al.

Rh2 synergistically enhances paclitaxel or mitoxantrone in prostate cancer models

Author(s): Xie X, Eberding A, Madera C, Fazli L, Jia W, et al.

Liquid chromatographic determination of less polar ginsenosides in processed ginseng

Author(s): Kwon SW, Han SB, Park IH, Kim JM, Park MK, et al.

[Determination of ginsenoside Rd and its metabolites in rat urine by LC-MS]

Author(s): Yang L, Xu SJ, Zeng X, Liu YM, Deng SG, et al.

Determination of Ginsenoside Rh2 in Enzyme Conversion by HPLC

Author(s): Jiang L, Zhao S, Ya L, Li J